European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene), Initial reports. Luxembourg: Publications Office of the European Union.
Preview | Title | Contact |
---|---|---|
|
PDF (Isotonitazene initial report)
- Published Version
409kB |
Isotonitazene is a synthetic opioid analgesic monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2019. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended). Its purpose is to provide scientific evidence to the Commission to allow it to make an informed decision regarding whether or not there is a need to request a risk assessment on a new psychoactive substance.
B Substances > New (novel) psychoactive substances
L Social psychology and related concepts > Legal availability or accessibility
MM-MO Crime and law > Crime > Substance related crime > Crime associated with substance production and distribution
VA Geographic area > Europe
Repository Staff Only: item control page